Development of Resistance to Amphotericin B in Candida lusitaniae Infecting a Human

Candida lusitaniae associated with infection in a patient with acute myelogenous leukemia developed resistance to amphotericin B during systemic treatment of the patient. The organism, when isolated initially, was inhibited by 0.31 μg of amphotericin B per ml in yeast nitrogen base agar, but when is...

תיאור מלא

מידע ביבליוגרפי

הוצא לאור ב:	Antimicrob Agents Chemother
Principais autores:	Pappagianis, D., Collins, M. S., Hector, R., Remington, J.
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	American Society for Microbiology (ASM) 1979
נושאים:	Pharmacology and Therapeutics
גישה מקוונת:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC352808/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/290351/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.16.2.123
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!